Caribou Biosciences at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Caribou Biosciences is at ASH 2026 in New Orleans. Caribou Biosciences supports a symposium on CAR-T cell therapy for lymphoma, run by PeerView Institute for Medical Education. Its expert workshops cover current CAR-T standards, where the therapy fits in the treatment sequence and emerging cellular therapy platforms.
| Organization | ASH 2026 Attendance |
|---|---|
Caribou Biosciences Berkeley, CA | |
Clinical-stage CRISPR genome-editing company developing off-the-shelf allogeneic CAR-T cell therapies for blood cancers. | Symposium Fri Dec 11 7:00pm–10:00pm Accelerating CARs for Lymphoma: Expert Workshops on CAR-T Standards, Sequencing, and Emerging Cellular Therapy Platforms CAR-T as standard lymphoma care and what comes next, including dual-target, faster-manufactured, and in vivo versions that could widen patient access. |
Find decision makers at Caribou Biosciences
Tell us what you sell and we’ll find the people at Caribou Biosciences most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction